D. Boral Capital Reaffirms “Buy” Rating for NRx Pharmaceuticals (NASDAQ:NRXP)
NRx Pharmaceuticals (NASDAQ:NRXP – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at D. Boral Capital in a research report issued to clients and investors on Monday,Benzinga reports. They presently have a $31.00 target price on the stock. Other research analysts also recently issued research reports about the stock. Ascendiant Capital Markets […]
NRx Pharmaceuticals (NASDAQ:NRXP – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at D. Boral Capital in a research report issued to clients and investors on Monday,Benzinga reports. They presently have a $31.00 target price on the stock. Other research analysts also recently issued research reports about the stock. Ascendiant Capital Markets […]
